Correlation Between Boston Scientific and Vivos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boston Scientific and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Scientific Corp and Vivos Therapeutics, you can compare the effects of market volatilities on Boston Scientific and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and Vivos Therapeutics.

Diversification Opportunities for Boston Scientific and Vivos Therapeutics

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Boston and Vivos is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Boston Scientific i.e., Boston Scientific and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Boston Scientific and Vivos Therapeutics

Considering the 90-day investment horizon Boston Scientific Corp is expected to generate 0.15 times more return on investment than Vivos Therapeutics. However, Boston Scientific Corp is 6.66 times less risky than Vivos Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Vivos Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  5,599  in Boston Scientific Corp on September 20, 2024 and sell it today you would earn a total of  3,444  from holding Boston Scientific Corp or generate 61.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Boston Scientific Corp  vs.  Vivos Therapeutics

 Performance 
       Timeline  
Boston Scientific Corp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Vivos Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Boston Scientific and Vivos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boston Scientific and Vivos Therapeutics

The main advantage of trading using opposite Boston Scientific and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.
The idea behind Boston Scientific Corp and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing